FORT LAUDERDALE, FL and QUFU, CHINA — (MARKET WIRE) – Sunwin International Neutraceuticals, Inc. an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, will seek approval for “Hypericin” as a new veterinary medical application to treat avian flu. The Department of Livestock Farming for Shandong Province Government has recently submitted a fast-track application to the Livestock Farming Bureau of China Ministry of Agriculture for approval of Hypericin on behalf of Sunwin International Neutraceuticals, Inc. as a new veterinary medicine to treat avian flu virus. Hypericin is a derivative of St. Johns Wort, which is an English word for a Chinese herb manufactured by Sunwin. Sunwin has manufactured Hypericin since 1997. In recent laboratory tests, Hypericin has proven effective as a treatment for poultry infected with strands of the avian flu. The South China Agricultural University has recently finished a clinic test of a medicine developed by the Chinese Academy of Agricultural Sciences. The result showed hypericin, which is isolated from hypericum perforatum, had cured all poultry infected by the deadly H5N1 avian flu for the experiment. The in vitro experiments indicated that when H5N1 and H9N2 avian flu viruses were treated with hypericin at 3.72 mg/ml for 30 minutes, hypericin killed 100% of the viruses. When these viruses were treated with hypericin at 0.744 mg/ml for 10 minutes, hypericin killed over 99.99% of the viruses.
Laiwang Zhang, President and Chairman of Sunwin International Neutraceuticals, Inc., stated, “The approval could pave the way for Hypericin as a commercial application for the treatment of livestock populations in China. If approved, the demand for Hypericin should increase substantially worldwide. Furthermore, the new application can lead to successful development of the new medicine will not only help prevent the epidemic on birds and control the spread in those places which have reported outbreaks, but also can give some idea and experience to the development of new drug for human.”